The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trends in breast cancer death by stage at diagnoses in 2000-2018.
 
Adriana Matutino Kahn
No Relationships to Disclose
 
Michal Marczyk
No Relationships to Disclose
 
Andrea Silber
Honoraria - AstraZeneca/Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Mariya Rozenblit
Consulting or Advisory Role - AstraZeneca
 
Tara B. Sanft
No Relationships to Disclose
 
Michael DiGiovanna
No Relationships to Disclose
 
Sarah Schellhorn
Stock and Other Ownership Interests - Coronado Biosciences; Gilead Sciences; Roche
Consulting or Advisory Role - Cardinal Health; Celgene; Eisai; Puma Biotechnology
Research Funding - Genentech; Pfizer
 
Ian E. Krop
Employment - Freeline Therapeutics (I); PureTech (I)
Leadership - Freeline Therapeutics (I); PureTech (I)
Stock and Other Ownership Interests - Freeline Therapeutics (I); PureTech (I)
Honoraria - AstraZeneca; Genentech/Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genentech/Roche; Macrogenics; Merck; Novartis; Seagen
Research Funding - Genentech (Inst); Macrogenics (Inst); Pfizer (Inst)
 
Maryam B. Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Pfizer
Other Relationship - Cynosure/Hologic
 
Eric P. Winer
Consulting or Advisory Role - Carrick Therapeutics; Jounce Therapeutics; Leap Therapeutics
Research Funding - Genentech (Inst)
 
Lajos Pusztai
Honoraria - Athenex; bioTheranostics; natera; OncoCyte
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Bristol Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Pfizer; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine; NanoString Technologies